Literature DB >> 15098927

Dihydropiridines mechanism of action in striatal isolated nerve endings: comparison with omega-agatoxin IVA.

C A Galindo1, M Sitges.   

Abstract

The relative contribution of Ca2+ and Na+ channels to the mechanism underlying the action of the dihydropiridines (DHPs), nimodipine, nitrendipine and nifedipine was investigated in rat striatum synaptosomes. The rise in internal Ca2+ (Ca(i), as determined with fura-2) induced by high K+ was unchanged by the DHPs, which like tetrodotoxin (TTX) inhibited both the rise in internal Na+ (Na(i), as determined with the Na+ selective indicator dye, SBFI) and the rise in Ca(i) induced by veratridine. Nimodipine and nitrendipine were much more potent than nifedipine. Oppositely to TTX and to the DHPs, the P/Q type Ca2+ channel blocker, omega-agatoxin IVA did not inhibit the rise in Ca(i) induced by veratridine, but inhibited the rise in Ca(i) induced by high K+. Veratridine-evoked release of dopamine, GABA, Glu, and Asp (detected by HPLC) was inhibited by nimodipine, nitrendipine, and TTX, while high K+-evoked release was unchanged by the DHPs or TTX. It is concluded that the reduction in presynaptic Na+ channel permeability might contribute to the cerebral effects of DHPs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098927     DOI: 10.1023/b:nere.0000018836.82122.23

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  Calcium channels coupled to glutamate release identified by omega-Aga-IVA.

Authors:  T J Turner; M E Adams; K Dunlap
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

2.  Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels.

Authors:  M Sitges; F Peña; L M Chiu; A Guarneros
Journal:  Neurochem Int       Date:  1998-02       Impact factor: 3.921

Review 3.  Sodium channels as molecular targets for antiepileptic drugs.

Authors:  D S Ragsdale; M Avoli
Journal:  Brain Res Brain Res Rev       Date:  1998-03

4.  Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain.

Authors:  A Deffois; D Fage; C Carter
Journal:  Neurosci Lett       Date:  1996-12-13       Impact factor: 3.046

5.  The calcium channel blocker nitrendipine blocks sodium channels in neonatal rat cardiac myocytes.

Authors:  A Yatani; A M Brown
Journal:  Circ Res       Date:  1985-06       Impact factor: 17.367

6.  omega-Aga IVA selectively inhibits the calcium-dependent fraction of the evoked release of [3H]GABA from synaptosomes.

Authors:  M Sitges; L M Chiu
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

7.  Effect of organic and inorganic calcium channel blockers on gamma-amino-n-butyric acid release induced by monensin and veratrine in the absence of external calcium.

Authors:  M Sitges
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

8.  Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.

Authors:  P Zapater; J Javaloy; J F Román; M T Vidal; J F Horga
Journal:  Brain Res       Date:  1998-06-15       Impact factor: 3.252

9.  Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats.

Authors:  J N Wurpel; S N Iyer
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

10.  Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.

Authors:  D C Pang; N Sperelakis
Journal:  Biochem Pharmacol       Date:  1984-03-01       Impact factor: 5.858

View more
  1 in total

1.  Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na(+) and Ca(2+) Channels Permeability.

Authors:  María Sitges; Luz María Chiu; Ronald C Reed
Journal:  Neurochem Res       Date:  2015-11-05       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.